Gundelfingen, Germany

Dittmar Quade


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 1988

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovator Spotlight: Dittmar Quade - Revolutionizing Transdermal Calcium Antagonists

Introduction:

Dittmar Quade is an accomplished inventor hailing from Gundelfingen, Germany. With a keen focus on pharmaceutical innovations, he has made significant contributions to the field of transdermal drug delivery.

Latest Patents:

Quade's most notable patent is the "Transdermal application form of calcium antagonists", which revolutionizes the way calcium antagonists are administered. By utilizing permeation enhancers, Quade has developed transdermal dosage forms that are not only effective for humans but also for other mammals like bovines.

Career Highlights:

At Godecke Akt., a pharmaceutical company known for its groundbreaking research and development initiatives, Quade has been instrumental in spearheading innovative projects. His dedication to pushing the boundaries of drug delivery systems has earned him recognition as a visionary in the industry.

Collaborations:

Quade has had the privilege of collaborating with esteemed professionals in the field, including Kurt H Bauer and Majid Mahjour. Together, they have worked tirelessly to bring cutting-edge solutions to the market, leaving a lasting impact on the healthcare landscape.

Conclusion:

Dittmar Quade's pioneering work in transdermal drug delivery showcases his commitment to advancing pharmaceutical technologies. His patents and collaborations stand as a testament to his expertise and passion for driving innovation in the medical field. As Quade continues to push the boundaries of what is possible in drug delivery systems, the industry eagerly anticipates his next groundbreaking invention.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…